Skip to main content

Table 2 A commonly used risk group stratification scheme

From: First brachytherapy treatment of prostate cancer in Nigeria using low dose rate radioactive iodine 125

Risk group

Clinical stage

PSA

 

Gleason score

Low (0)

≤ T2b

AND

≤ 10

AND

≤ 6

Intermediate (1)

> T2b

OR

> 10

OR

> 6

High (≥ 2)

> T2b

AND/OR

> 10

AND/OR

> 6